COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,436 Articles (22,835 medRxiv, 8,601 bioRxiv)

Most recent first Previous |  Page 1293: Articles 12921-12930  | Next

Predictive factors of response to 3rd dose of COVID-19 mRNA vaccine in kidney transplant recipients
Charmetant, X., ESPI, M., Barba, T., Ovize, A., Morelon, E., Thaunat, O.
10.1101/2021.08.23.21262293 — Posted: 2021-08-30
A machine learning approach for identification of gastrointestinal predictors for the risk of COVID-19 related hospitalization
Liptak, P., Banovcin, P., Rosolanka, R., Prokopic, M., Kocan, I., Ziacikova, I., Uhrik, P., Grendar, M., Hyrdel, R.
10.1101/2021.08.27.21262728 — Posted: 2021-08-30
Can tracking mobility be used as a public health tool against COVID-19 following the expiration of stay-at-home mandates?
Her, P. H., Saeed, S., Tram, K. H., Bhatnagar, S. R.
10.1101/2021.08.27.21262629 — Posted: 2021-08-30
Intramuscular SARS-CoV-2 vaccines elicit varying degrees of plasma and salivary antibody responses as compared to natural infection
Nahass, G. R., Salomon-Shulman, R. E., Blacker, G., Haider, K., Brotherton, R., Teague, K., Yiu, Y. Y., Brewer, R. E., Galloway, S. D., Hansen, P., Marquez-Arreguin, G., Sheikh-Mohamed, S., Chao, G. Y. C., Isho, B., Do, E., Chang, I., Snow, T., Lee, A. S., STANFORD COVID-19 BIOBANK, , Manohar, M., Yang, S., Blomkalns, A. L., Rogers, A. J., McGeer, A., Gingras, A.-C., Straus, S., Grant, P., Nadeau, K. C., Blish, C. A., Gommerman, J. L., Sanders, E. C., Weissman, I. L., Tal, M. C.
10.1101/2021.08.22.21262168 — Posted: 2021-08-30
Opaganib in COVID-19 pneumonia: Results of a randomized, placebo-controlled Phase 2a trial
Winthrop, K. L., Skolnick, A. W., Rafiq, A., Beegle, S. H., Suszanski, J., Koehne, G., Barnett-Griness, O., Bibliowicz, A., Fathi, R., Anderson, P., Raday, G., Eagle, G., Katz Ben-Yair, V., Minkowitz, H. S., Levitt, M. L., Gordon, M. S.
10.1101/2021.08.23.21262464 — Posted: 2021-08-29
The effectiveness of SARS-CoV-2 vaccination in preventing severe illness and death- real-world data from a cohort of patients hospitalized with COVID-19.
Sagiraju, H. K. R., Elavarasi, A., Gupta, N., Kumar, R., Paul, S. S., Vig, S., Sirohiya, P., Ratre, B., Garg, R., Pandit, A., Nalwa, R., Kumar, B., Meena, V. P., Wig, N., Mittal, S., Pahuja, S., Madan, K., Das, N., Dwivedi, T., Gupta, R., Wundavalli, L., Singh, A. R., Singh, S., Mishra, A., Matharoo, K. S., Manisha, , Kumar, S., Mohan, A., Guleria, R., Bhatnagar, S.
10.1101/2021.08.26.21262705 — Posted: 2021-08-29
COVID-19-associated hospitalizations among vaccinated and unvaccinated adults >=18 years - COVID-NET, 13 states, January 1 - July 24, 2021
Havers, F. P., Pham, H., Taylor, C. A., Whitaker, M., Patel, K., Anglin, O., Kambhampati, A. K., Milucky, J., Zell, E., Chai, S. J., Kirley, P. D., Alden, N. B., Armistead, I., Yousey-Hindes, K., Meek, J., Openo, K. P., Anderson, E. J., Reeg, L., Kohrman, A., Lynfield, R., Como-Sabetti, K., Davis, E. M., Cline, C., Muse, A., Barney, G., Bushey, S., Felsen, C. B., Billing, L. M., Shiltz, E., Sutton, M., Abdullah, N., Talbot, H. K., Schaffner, W., Hill, M., George, A., Murthy, B. P., McMorrow, M.
10.1101/2021.08.27.21262356 — Posted: 2021-08-29 Discussion: Onsite
Antibodies anti-SARS-CoV2 time-course in patients and vaccinated subjects: an evaluation of the harmonization of two different methods
Dittadi, R., Seguso, M., Isabella, B., Afshar, H., Carraro, P.
10.1101/2021.08.28.21262543 — Posted: 2021-08-29
Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape
Bushman, M., Taylor, B. P., Kahn, R., Lipsitch, M., Hanage, W. P.
10.1101/2021.08.26.21262579 — Posted: 2021-08-29
Previous Infection Combined with Vaccination Produces Neutralizing Antibodies With Potency Against SARS-CoV-2 Variants
Ibarrondo, F. J., Hofmann, C., Ali, A., Ayoub, P., Kohn, D. B., Yang, O. O.
10.1101/2021.08.27.21262744 — Posted: 2021-08-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).